1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001; 94:153–6.
Article
2. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334:693–9.
Article
3. Tan KC, Rela M, Ryder SD, et al. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg. 1995; 82:253–6.
Article
4. McPeake JR, O'Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol. 1993; 18:226–34.
Article
5. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001; 33:1394–403.
Article
6. Gondolesi GE, Roayaie S, Muñoz L, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg. 2004; 239:142–9.
7. Todo S, Furukawa H; Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg. 2004; 240:451–9.
8. Lee SG, Hwang S, Moon DB, et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl. 2008; 14:935–45.
Article
9. Miltiadous O, Sia D, Hoshida Y, et al. Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation. J Hepatol. 2015; 63:1368–77.
Article
10. Korean Liver Cancer Study Group (KLCSG); National Cancer Center Korea (NCC). 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Gut Liver. 2015; 9:267–317.
11. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl. 2005; 11:1265–72.
Article
12. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17:1471–4.
Article
13. The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan. Jpn J Surg. 1989; 19:98–129.
14. R Core Team. R: A language and environment for statistical computing [Internet]. Vienna: R Foundation for Statistical Computing;2015. [cited 2016 Nov 1]. Available from:
https://www.R-project.org/.
15. Hothorn T, Hornik K, van de Wiel MA, Zeileis A. Implementing a class of permutation tests: the coin package. J Stat Softw. 2008; 28:1–23.
16. Hothorn T, Hornik K, van de Wiel MA, Zeileis A. A Lego system for conditional inference. Am Stat. 2006; 60:257–63.
Article
17. Kaido T, Morita S, Tanaka S, et al. Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Dis Markers. 2015; 2015:425926.
Article
18. Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003; 38:200–7.
Article
19. Scortegagna E Jr, Karam AR, Sioshansi S, Bozorgzadeh A, Barry C, Hussain S. Hepatocellular carcinoma recurrence pattern following liver transplantation and a suggested surveillance algorithm. Clin Imaging. 2016; 40:1131–4.
Article
20. Attard G, de Bono JS. Utilizing circulating tumor cells: challenges and pitfalls. Curr Opin Genet Dev. 2011; 21:50–8.
Article
21. Zhang Y, Li J, Cao L, Xu W, Yin Z. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives. Semin Oncol. 2012; 39:449–60.
Article
22. Zhang Y, Shi ZL, Yang X, Yin ZF. Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis. World J Gastroenterol. 2014; 20:142–7.
Article
23. Donat M, Alonso S, Pereira F, et al. Impact of histological factors of hepatocellular carcinoma on the outcome of liver transplantation. Transplant Proc. 2016; 48:1968–77.
Article
24. Mejia GA, Gomez MA, Serrano J, et al. Correlation between the radiologic and histologic size of hepatocellular carcinoma in patients eligible for liver transplantation. Transplant Proc. 2006; 38:1394–5.
Article
25. El Moghazy W, Kashkoush S, Meeberg G, Kneteman N. Incidence, characteristics, and prognosis of incidentally discovered hepatocellular carcinoma after liver transplantation. J Transplant. 2016; 2016:1916387.
Article